Evaluation and Management of Unilateral Neck Swelling with Pruritus
Do not routinely prescribe antibiotics for this presentation unless clear signs of bacterial infection are present (fever, erythema, warmth, fluctuance), as most adult neck masses are neoplastic rather than infectious, and empiric antibiotics delay cancer diagnosis. 1
Initial Risk Stratification
Your immediate priority is determining malignancy risk through focused history and examination, as this drives all subsequent management decisions.
High-Risk Features Requiring Urgent Workup
History red flags 1:
- Mass present ≥2 weeks without significant fluctuation
- No clear infectious etiology
- Uncertain duration of symptoms
Physical examination red flags 1:
- Size >1.5 cm
- Firm consistency
- Fixation to adjacent tissues
- Ulceration of overlying skin
Additional concerning features 1:
- Age >40 years
- Tobacco or alcohol use
- Unexplained weight loss
- Dysphagia, odynophagia, or voice changes
- Cranial neuropathies
The Pruritus Component
While pruritus is not specifically addressed in neck mass guidelines, it does not exclude malignancy. The itch may represent:
- Overlying skin irritation from the mass
- Inflammatory response
- Rarely, paraneoplastic phenomenon
Do not be falsely reassured by the presence of itch—proceed with standard malignancy risk assessment.
Management Algorithm
If High-Risk Features Present:
Perform or refer for targeted physical examination 1
- Visualize larynx, base of tongue, and pharynx (requires laryngoscopy)
- Palpate entire neck for additional masses
- Examine oral cavity thoroughly
Order contrast-enhanced CT neck (or MRI if CT contraindicated) 1
- This is a strong recommendation from guidelines
- Do not delay imaging to "watch and wait"
Arrange fine-needle aspiration (FNA) 1
- Preferred over open biopsy when diagnosis remains uncertain after imaging
- Strong recommendation to avoid open biopsy initially
If cystic on imaging or FNA 1, 2
- Continue evaluation until diagnosis obtained
- Do not assume benign—cystic metastases from HPV-positive oropharyngeal cancer are increasingly common 1
Patient education 1
- Explain malignancy risk explicitly
- Discuss planned diagnostic tests
If Low-Risk Features:
Establish close follow-up plan 1
- Document specific timeline (typically 2-4 weeks)
- Provide explicit return criteria:
- Mass enlargement
- Development of any high-risk features
- Persistence beyond 4-6 weeks
- New systemic symptoms
Consider symptomatic treatment for pruritus
- Topical antihistamines or corticosteroids if skin involvement
- Oral antihistamines for symptomatic relief
Critical Pitfalls to Avoid
The antibiotic trap 1: The 2017 AAO-HNS guidelines emphasize that most adult neck masses are neoplastic, not infectious. Prescribing empiric antibiotics:
- Delays cancer diagnosis (potentially by weeks to months)
- Provides false reassurance when mass temporarily decreases
- Contributes to antibiotic resistance
- Increases healthcare costs
Only prescribe antibiotics if bacterial infection is clinically evident: fever, erythema, warmth, fluctuance, or systemic signs of infection.
The "watch and wait" error: A mass present ≥2 weeks without clear infectious cause requires imaging, not observation 1.
Assuming cystic = benign: HPV-positive oropharyngeal squamous cell carcinoma frequently presents as cystic neck metastases in younger patients without traditional risk factors 1. Continue workup until diagnosis confirmed.
Missing the deep examination: Superficial neck examination is insufficient. High-risk patients require visualization of the upper aerodigestive tract mucosa 1.
Special Considerations
Vascular causes: If mass is pulsatile, consider ultrasound first to evaluate for vascular etiology (tortuous vessel, paraganglioma) 2. However, this is uncommon with pruritus.
Inflammatory causes: Rare entities like TIPIC syndrome (transient perivascular inflammation of carotid artery) 3 or Lemierre syndrome 4 exist but typically present with pain rather than pruritus and have specific clinical contexts.
The unilateral presentation: Unilaterality does not reduce malignancy concern—many head and neck cancers present with unilateral cervical lymphadenopathy 1.